Luoxin Pharmaceuticals Group Stock Co., Ltd. (SHE:002793)
China flag China · Delayed Price · Currency is CNY
4.760
-0.030 (-0.63%)
Jul 29, 2026, 3:04 PM CST

SHE:002793 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
2,3732,2732,6472,3643,5886,478
Revenue Growth
-2.78%-14.12%11.99%-34.11%-44.62%6.26%
Gross Profit
1,2241,0921,0401,024893.983,246
Operating Income
-152.47-158.6-476.89-479.63-1,600519.59
Net Income
-270.08-288.58-965.5-661.14-1,225406.1
Earnings Per Share
-0.25-0.27-0.91-0.61-0.860.28
EPS Growth
-----27.27%

Revenue by Segment

Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Jan '22
Pharmaceutical Industry
2,0112,3572,0741,4483,936
Pharmaceutical Commercial
203.56257.93255.062,0222,433
Unallocated Other Business
59.0932.735.27117.61108.29
Total
2,2732,6472,3643,5886,478

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
806.45554.11457.936951,4512,034
Total Debt
1,2271,0981,6401,5203,6222,858
Net Cash (Debt)
-420.73-543.68-1,182-825.31-2,171-823.17
Net Cash Growth
------
Net Cash Per Share
-0.40-0.51-1.11-0.76-1.52-0.57

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
238.2253.07-157.85466.89-939.13120.63
Capital Expenditures
-30.7-32.18-115.35-242.39-194.82-309.03
Free Cash Flow
207.5220.88-273.2224.5-1,134-188.4
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
51.58%48.02%39.30%43.33%24.92%50.10%
Operating Margin
-6.42%-6.98%-18.01%-20.29%-44.59%8.02%
Pretax Margin
-11.13%-12.79%-35.99%-25.56%-40.78%7.49%
Profit Margin
-11.38%-12.69%-36.47%-27.97%-34.14%6.27%
FCF Margin
8.74%9.72%-10.32%9.50%-31.61%-2.91%

Dividends

Fiscal YearFY 2021
Period EndingJan '22
Dividend Per Share
0.030
Dividend Per Share Growth
-40.00%
Dividend Yield
0.29%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
-----37.38
P/FCF Ratio
24.9523.07-25.97--
PS Ratio
2.182.241.532.472.332.34